A prospective randomized controlled trial of bone metabolism in patients with charcot foot
BACKGROUND: Diabetic neuroosteoarthropathy (DNOAP, Charcot’s foot) - is a progressive destructive inflammatory disease of the osteoarticular apparatus of the foot, untimely and inadequate treatment of which can lead to the formation of gross deformities. More often, DNOAP is unilateral, bi...
Guardado en:
Autores principales: | Ekaterina L. Zaitseva, Alla Y. Tokmakova, Viktor M. Zhilyaev, Natalia M. Malysheva, Natalia I. Sazonova, Gagik R. Galstyan, Aleksandr V. Vorontsov |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/41a8f461f9764e838d767425160cd468 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Surgical treatment of Charcot foot with purulent infection
por: Valeriy Afanas'evich Mitish, et al.
Publicado: (2009) -
Criteria of immobilization duration of the affected foot in diabetic Charcot neuro-osteoarthropathy
por: Anastasia Gennad'evna Demina, et al.
Publicado: (2014) -
Changes in loading distribution in patients with Charcot foot during long-term follow-up
por: Anastasia G. Demina, et al.
Publicado: (2018) -
Short-term outcomes of treatment of active stage of Charcot foot in outpatient setting
por: Anastasia G. Demina, et al.
Publicado: (2020) -
The use of orthopaedic shoes in patients with diabetes at high risk of foot amputation and Charcot arthropathy
por: Anastasia Gennagyevna Demina, et al.
Publicado: (2015)